The Original Article was published on 11 February 2026.
Correction to: Nature https://doi.org/10.1038/s41586-026-10106-5 Published online 11 February 2026.
In the version of the article initially published, in the source data for Extended Data Fig. 10d, the data listed for mouse #19277 (column O) were inadvertently duplicated from the mouse #19278 column (column Y). Extended Data Fig. 10d and its source data have now been corrected in the HTML and PDF versions of the article. The original and corrected panels are shown below in Fig. 1.
Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Bin Li, Ming-Chao Zhong, Cristian Camilo Galindo, Jiayu Dou, Jin Qian, Zhenghai Tang, Dominique Davidson & André Veillette.
Department of Medicine, University of Montréal, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
Bin Li, Cristian Camilo Galindo, Jiayu Dou & André Veillette.
Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China.
MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Search author on:PubMed Google Scholar.
Correspondence to André Veillette.
Li, B., Zhong, MC., Galindo, C.C. et al. Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer. Nature (2026). https://doi.org/10.1038/s41586-026-11409-3.
Version of record: 12 November 2026.
DOI: https://doi.org/10.1038/s41586-026-11409-3.
Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative.
